Stay updated on PROMO: Pembrolizumab in Osteosarcoma Clinical Trial

Sign up to get notified when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Footer revision label updated from v3.3.3 to v3.3.4. There are no changes to the study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:44:44.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A new site revision label 'Revision: v3.3.3' appears and the 'HHS Vulnerability Disclosure' link is removed; these are minor UI/site maintenance changes rather than study content updates.
    Difference
    0.1%
    Check dated 2025-12-23T20:22:50.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Publication sourcing text updated to clarify that entries in Publications are auto-filled from PubMed and may not all pertain to the study. The revision tag on the page updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T21:22:06.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Removed the site-wide government funding/status notice from the page; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T19:15:21.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The two screenshots show only minor UI adjustments to the study page; core content such as the study design, eligibility criteria, outcomes, and enrollment appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T13:47:23.000Z thumbnail image
  8. Check
    101 days ago
    Change Detected
    Summary
    - Added a government funding notice impacting information currency and operations, plus a resource link for Bone osteosarcoma, and updated revision to v3.2.0. - Removed the previous revision v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T02:15:48.000Z thumbnail image

Stay in the know with updates to PROMO: Pembrolizumab in Osteosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.